Using the publicly available pan-cancer TCGA dataset, we also observed a correlation between POLQ mRNA overexpression and TP53 mutation status in breast, lung, bladder, colorectal, gastric, glioblastoma, pancreatic, prostate, melanoma and uterine cancers (Figure 5B) (46–48). Here, POLQ is linked to melanoma.